Clinical Trial Update: Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/Phase 3 trial of immunosuppressive treatment for chronic virus-negative inflammatory cardiomyopathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Cardiomyopathy

Snippet

Sponsor: LMU Klinikum | Conditions: Inflammatory Cardiomyopathy | Phase 2, Phase 3 | Status: TERMINATED